Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study

por Ou, Huang-Tz, Chang, Kai-Cheng, Li, Chung-Yi, Wu, Jin-Shang
Publicado 2016

Comparative Effectiveness and Safety of Standard-Dose and Low-Dose Pembrolizumab in Patients with Non-Small-Cell Lung Cancer: A Multi-Institutional Cohort Study in Taiwan

por Chang, Kai-Cheng, Shao, Shih-Chieh, Chen, Hui-Yu, Chan, Yuk-Ying, Fang, Yueh-Fu
Publicado 2022

Quantifying the Effects of Climate Factors on Carbon Monoxide Poisoning: A Retrospective Study in Taiwan

por Wang, Chien-Ho, Shao, Shih-Chieh, Chang, Kai-Cheng, Hung, Ming-Jui, Yang, Chen-Chang, Liao, Shu-Chen
Publicado 2021

Guillain-​Barré Syndrome Associated with COVID-19 Vaccination

por Shao, Shih-Chieh, Wang, Chien-Ho, Chang, Kai-Cheng, Hung, Ming-Jui, Chen, Hui-Yu, Liao, Shu-Chen
Publicado 2021

Comparative effectiveness of dulaglutide versus liraglutide in Asian type 2 diabetes patients: a multi-institutional cohort study and meta-analysis

por Chang, Kai-Cheng, Shao, Shih-Chieh, Kuo, Shihchen, Yang, Chen-Yi, Chen, Hui-Yu, Chan, Yuk-Ying, Ou, Huang-Tz
Publicado 2020

APE1 distinguishes DNA substrates in exonucleolytic cleavage by induced space-filling

por Liu, Tung-Chang, Lin, Chun-Ting, Chang, Kai-Cheng, Guo, Kai-Wei, Wang, Shuying, Chu, Jhih-Wei, Hsiao, Yu-Yuan
Publicado 2021

Risk of Thrombosis Following the First Dose of ChAdOx1 nCoV-19 Vaccine in Patients Undergoing Maintenance Hemodialysis: A Self-Controlled Case Series Study

por Shao, Shih-Chieh, Liao, Tzu-Chi, Chang, Kai-Cheng, Chen, Hui-Yu, Lin, Swu-Jane, Hsieh, Cheng-Yang, Lai, Edward Chia-Cheng
Publicado 2023

Differences in outcomes of hospitalizations for heart failure after SGLT2 inhibitor treatment: effect modification by atherosclerotic cardiovascular disease

por Shao, Shih-Chieh, Chang, Kai-Cheng, Lin, Swu-Jane, Chang, Shang-Hung, Hung, Ming-Jui, Chan, Yuk-Ying, Lai, Edward Chia-Cheng
Publicado 2021

Sodium glucose co-transporter 2 inhibitors and cardiovascular event protections: how applicable are clinical trials and observational studies to real-world patients?

por Shao, Shih-Chieh, Lin, Yi-Han, Chang, Kai-Cheng, Chan, Yuk-Ying, Hung, Ming-Jui, Kao Yang, Yea-Huei, Lai, Edward Chia-Cheng
Publicado 2019

Factors predictive of clinical outcome in advanced hepatocellular carcinoma patients receiving ramucirumab treatment: A real‐world experience

por Lin, Po‐Ting, Hung, Min‐Hua, Shao, Shih‐Chieh, Chen, Hui‐Yu, Chan, Yuk‐Ying, Chang, Kai‐Cheng, Lin, Shi‐Ming, Ou, Huang‐Tz
Publicado 2023

Comparative risk evaluation for cardiovascular events associated with dapagliflozin vs. empagliflozin in real-world type 2 diabetes patients: a multi-institutional cohort study

por Shao, Shih-Chieh, Chang, Kai-Cheng, Hung, Ming-Jui, Yang, Ning-I, Chan, Yuk-Ying, Chen, Hui-Yu, Kao Yang, Yea-Huei, Lai, Edward Chia-Cheng
Publicado 2019

Favorable pleiotropic effects of sodium glucose cotransporter 2 inhibitors: head-to-head comparisons with dipeptidyl peptidase-4 inhibitors in type 2 diabetes patients

por Shao, Shih-Chieh, Chang, Kai-Cheng, Lin, Swu-Jane, Chien, Rong-Nan, Hung, Ming-Jui, Chan, Yuk-Ying, Kao Yang, Yea-Huei, Lai, Edward Chia-Cheng
Publicado 2020

Comparison of Sodium-Glucose Cotransporter 2 Inhibitors vs Glucagonlike Peptide-1 Receptor Agonists and Incidence of Dry Eye Disease in Patients With Type 2 Diabetes in Taiwan

por Su, Yu-Chen, Hung, Jia-Horung, Chang, Kai-Cheng, Sun, Chi-Chin, Huang, Yi-Hsun, Lee, Chaw-Ning, Hung, Ming-Jui, Lai, Chi-Chun, Shao, Shih-Chieh, Lai, Edward Chia-Cheng
Publicado 2022